New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis

FHS
April 5, 2024
9:57 am

The performance of tuberculin skin test (TST) and interferon-γ release assays (IGRAs) in predicting tuberculosis (TB).

Fore scores $75M Series D, tees up new leadership with ex-Elevation CEO Shawn Leland at the helm — for now

Fore Biotherapeutics has reeled in a $75 million Series D, and its CEO Matthew Ros is walking off the course for “other professional pursuits,” the

August 24, 2023

EMA calls for member states to lend a hand to ease GLP-1 supply bottlenecks

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 27, 2024

Dangers and deaths around Black pregnancies seen as a ‘completely preventable’ health crisis

Tonjanic Hill was overjoyed in 2017 when she learned she was 14 weeks pregnant. Despite a history of uterine fibroids, she never lost faith that

August 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.